Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 86

1.

Approach to a Posterior Cervico-mediastinal Ganglioneuroma.

Lee F, Yu W, Loor G, Burt BM.

Ann Thorac Surg. 2018 Oct 23. pii: S0003-4975(18)31519-4. doi: 10.1016/j.athoracsur.2018.08.092. [Epub ahead of print]

PMID:
30365962
2.

Current and Future Management of Malignant Mesothelioma: A Consensus Report from the National Cancer Institute Thoracic Malignancy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation.

Tsao AS, Lindwasser OW, Adjei AA, Adusumilli PS, Beyers ML, Blumenthal GM, Bueno R, Burt BM, Carbone M, Dahlberg SE, de Perrot M, Fennell DA, Friedberg J, Gill RR, Gomez DR, Harpole DH Jr, Hassan R, Hesdorffer M, Hirsch FR, Hmeljak J, Kindler HL, Korn EL, Liu G, Mansfield AS, Nowak AK, Pass HI, Peikert T, Rimner A, Robinson BWS, Rosenzweig KE, Rusch VW, Salgia R, Sepesi B, Simone CB 2nd, Sridhara R, Szlosarek P, Taioli E, Tsao MS, Yang H, Zauderer MG, Malik SM.

J Thorac Oncol. 2018 Nov;13(11):1655-1667. doi: 10.1016/j.jtho.2018.08.2036. Epub 2018 Sep 25.

PMID:
30266660
3.

Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation.

Lee HS, Jang HJ, Lo EM, Truong CY, Groth SS, Friedberg JS, Sugarbaker DJ, Burt BM.

Interact Cardiovasc Thorac Surg. 2018 Aug 27. doi: 10.1093/icvts/ivy248. [Epub ahead of print]

PMID:
30165653
4.

Standardizing the time-honored wedge resection.

Hamaji M, Miyahara S, Lee HS, Burt BM.

J Thorac Dis. 2018 Jul;10(Suppl 18):S2206-S2208. doi: 10.21037/jtd.2018.06.155. No abstract available.

5.

Mutation Ensemble for Response to Programmed Cell Death 1 Inhibition in Thymic Carcinoma.

Lee HS, Truong CY, Burt BM.

J Thorac Oncol. 2018 Aug;13(8):e150-e152. doi: 10.1016/j.jtho.2018.03.027. No abstract available.

PMID:
30049379
6.

A Phase I Trial of Surgical Resection and Intraoperative Hyperthermic Cisplatin and Gemcitabine for Pleural Mesothelioma.

Burt BM, Richards WG, Lee HS, Bartel S, Dasilva MC, Gill RR, Jaklitsch MT, Johnson BE, Swanson SJ, Bueno R, Sugarbaker DJ.

J Thorac Oncol. 2018 Sep;13(9):1400-1409. doi: 10.1016/j.jtho.2018.04.032. Epub 2018 May 9.

PMID:
29753120
7.

Guidelines for stereotactic body radiation therapy treatment of lung cancer highlight important research questions: what is the next step?

Cornwell LD, Korb ML, Burt BM.

J Thorac Dis. 2018 Mar;10(3):1339-1342. doi: 10.21037/jtd.2018.03.36. No abstract available.

8.

Giant Mediastinal Liposarcoma: A Rare Yet Distinct Clinical Entity.

Nguyen DC, Olatubosun O, Yu W, Loor G, Burt BM.

Ann Thorac Surg. 2018 Sep;106(3):e117-e119. doi: 10.1016/j.athoracsur.2018.03.018. Epub 2018 Apr 12.

PMID:
29654722
9.

IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer.

You R, DeMayo FJ, Liu J, Cho SN, Burt BM, Creighton CJ, Casal RF, Lazarus DR, Lu W, Tung HY, Yuan X, Hill-McAlester A, Kim M, Perusich S, Cornwell L, Rosen D, Song LZ, Paust S, Diehl G, Corry D, Kheradmand F.

Cancer Immunol Res. 2018 Jun;6(6):645-657. doi: 10.1158/2326-6066.CIR-17-0554. Epub 2018 Apr 13.

PMID:
29653981
10.

Thoracic outlet syndrome for thoracic surgeons.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Sep;156(3):1318-1323.e1. doi: 10.1016/j.jtcvs.2018.02.096. Epub 2018 Mar 13. No abstract available.

PMID:
29628349
11.

Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma.

Lee HS, Jang HJ, Choi JM, Zhang J, de Rosen VL, Wheeler TM, Lee JS, Tu T, Jindra PT, Kerman RH, Jung SY, Kheradmand F, Sugarbaker DJ, Burt BM.

JCI Insight. 2018 Apr 5;3(7). pii: 98575. doi: 10.1172/jci.insight.98575. [Epub ahead of print]

12.

Therapeutic R2 resection for pleural mesothelioma.

Nguyen D, Sugarbaker DJ, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jun;155(6):2734-2735. doi: 10.1016/j.jtcvs.2018.01.025. Epub 2018 Feb 1. No abstract available.

PMID:
29477257
13.

The printed trachea.

Patel V, Burt BM.

J Thorac Dis. 2017 Oct;9(10):3672-3673. doi: 10.21037/jtd.2017.09.49. No abstract available.

14.

The importance of R0.

Ibrahim K, Burt BM.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):428-429. doi: 10.1016/j.jtcvs.2017.09.064. No abstract available.

PMID:
29245203
15.

Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.

Padda SK, Terrone D, Tian L, Khuong A, Neal JW, Riess JW, Berry MF, Hoang CD, Burt BM, Leung AN, Schwartz EJ, Shrager JB, Wakelee HA.

J Thorac Imaging. 2018 May;33(3):176-183. doi: 10.1097/RTI.0000000000000310.

PMID:
29219888
16.

Paraneoplastic Syndromes and Thymic Malignancies: An Examination of the International Thymic Malignancy Interest Group Retrospective Database.

Padda SK, Yao X, Antonicelli A, Riess JW, Shang Y, Shrager JB, Korst R, Detterbeck F, Huang J, Burt BM, Wakelee HA, Badve SS.

J Thorac Oncol. 2018 Mar;13(3):436-446. doi: 10.1016/j.jtho.2017.11.118. Epub 2017 Nov 27.

PMID:
29191778
17.

Programmed death ligand 1-associated antitumor immunity in early-stage non-small cell lung cancer: Expression of major histocompatibility complex I as a prerequisite.

Burt BM.

J Thorac Cardiovasc Surg. 2018 Jan;155(1):393-394. doi: 10.1016/j.jtcvs.2017.08.061. Epub 2017 Sep 1. No abstract available.

PMID:
28967424
18.

Soluble Mesothelin-Related Peptides to Monitor Recurrence After Resection of Pleural Mesothelioma.

Burt BM, Lee HS, Lenge De Rosen V, Hamaji M, Groth SS, Wheeler TM, Sugarbaker DJ.

Ann Thorac Surg. 2017 Nov;104(5):1679-1687. doi: 10.1016/j.athoracsur.2017.06.042. Epub 2017 Sep 28.

PMID:
28964420
19.

Subspecialty certification in thoracic oncology: Toward your next diploma.

Groth SS, Burt BM.

J Thorac Cardiovasc Surg. 2017 Oct;154(4):1393-1394. doi: 10.1016/j.jtcvs.2017.08.001. Epub 2017 Aug 12. No abstract available.

PMID:
28918926
20.

Extending the survival advantage of ground glass.

Lee F, Burt BM.

J Thorac Dis. 2017 Jul;9(7):1828-1830. doi: 10.21037/jtd.2017.06.83. No abstract available.

Supplemental Content

Support Center